Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
---|
07/13/1995 | CA2179986A1 Treatment using arachidonic acid metabolite and particulate formulations |
07/12/1995 | EP0662481A1 Spiro piperidines and homologs promote release of growth hormone |
07/12/1995 | EP0662075A1 Prostaglandin analog for treating osteoporosis |
07/06/1995 | WO1995018141A1 Medicinal composition for bone resorption inhibition and osteogenesis acceleration |
07/06/1995 | WO1995018128A1 Pyrazolopyridine adenosine antagonists |
07/06/1995 | WO1995017904A2 Botulinum toxins for treating various disorders and associated pain |
07/06/1995 | CA2682117A1 The use of the neurotoxic component of a botulinum toxin for the treatment of a facial disease, disorder or condition |
07/06/1995 | CA2589968A1 The use of the neurotoxic component of a botulinum toxin for the treatment of pain associated with muscle activity or contracture |
07/06/1995 | CA2300771A1 Method for treating a mucus secretion |
07/06/1995 | CA2300723A1 Method for treating pain associated with a muscle disorder |
07/06/1995 | CA2300451A1 Method for treating a pyloric valve disease |
07/06/1995 | CA2300433A1 Method for treating a lacrimation disorder |
07/06/1995 | CA2180253A1 Pyrazolopyridine adenosine antagonists |
07/04/1995 | US5430051 Photodynamic diagnosis and therapy of rheumatic diseases |
06/29/1995 | WO1995017207A1 Parathyroid hormone formulation |
06/29/1995 | WO1995011013A3 Combination of progesterone antagonists and anti-oestrogens with partial agonistic action for use in hormone-replacement therapy for peri- and post-menopausal women |
06/27/1995 | US5428181 Treatment of bone disorders, osteoporosis |
06/27/1995 | CA2088274C Calcium and trace mineral supplements |
06/27/1995 | CA1336099C Urea based lipoxygenase compounds |
06/22/1995 | WO1995016689A1 IMPROVED PROCESS FOR THE SYNTHESIS OF 2-AMINO-3,5-DIHYDRO-7-SUBSTITUTED-4H-PYRROLO[3,2-d]PYRIMIDIN-4-ONES |
06/22/1995 | WO1995010271A3 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders |
06/22/1995 | CA2176040A1 Improved process for the synthesis of 2-amino-3,5-dihydro-7-substituted-4h-pyrrolo[3,2-d]pyrimidin-4-ones |
06/21/1995 | EP0658348A2 Aqueous solution inclusion complexes of benzothiophene compounds with cyclodextrins |
06/20/1995 | US5426122 Methods for reducing blood pressure with dimercaptosuccinic acid (DMSA) |
06/15/1995 | WO1995016035A2 Bmp-12, bmp-13 and tendon-inducing compositions thereof |
06/15/1995 | WO1995016033A1 C5a RECEPTOR ANTAGONISTS HAVING SUBSTANTIALLY NO AGONIST ACTIVITY |
06/15/1995 | WO1995015758A1 Aryl and heteroaryl quinazoline compounds which inhibit csf-1r receptor tyrosine kinase |
06/15/1995 | WO1995007108A3 Formulations for delivery of osteogenic proteins |
06/15/1995 | CA2176825A1 C5a receptor antagonists having substantially no agonist activity |
06/15/1995 | CA2137533A1 Aqueous solution inclusion complexes of benzothiophene compounds with water soluble cyclodextrins, and pharmaceutical formulations and methods thereof |
06/14/1995 | EP0657468A1 Human stromae derived factor |
06/14/1995 | EP0657029A1 Calcium receptor active molecules |
06/14/1995 | EP0656906A1 A novel endothelial cell molecule mediating lymphocyte binding in man |
06/14/1995 | EP0656784A1 Parathyroid hormone fragments and analogs |
06/14/1995 | CN1028866C Method for preparation of methylene bis-phosphonic acid derivatives |
06/13/1995 | US5424293 Phenylimidazolidine derivatives and their use |
06/08/1995 | WO1995015316A1 Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation |
06/08/1995 | CA2604073A1 Poly-.beta.-1.fwdarw.4-n-acetylglucosamine |
06/07/1995 | EP0656348A2 Aceric acid derivatives as medicaments |
06/06/1995 | US5422359 α-aminoketone derivatives |
06/01/1995 | WO1995014778A2 Dna sequence coding for a bmp receptor |
06/01/1995 | WO1995014714A1 Novel integrin-binding peptides |
06/01/1995 | WO1995014696A1 Hindered esters of rapamycin and their use as pharmaceuticals |
06/01/1995 | WO1995014662A1 26,28-methylene-1alpha,25-dihydroxyvitamin d2 compounds |
06/01/1995 | CA2177070A1 Novel integrin-binding peptides |
06/01/1995 | CA2176955A1 Hindered esters of rapamycin and their use as pharmaceuticals |
05/31/1995 | EP0655250A1 Compositions of Padina algae or their extracts, and their pharmaceutical, food compositions, or use for the culture of molluscs or arthropodes |
05/31/1995 | EP0542912B1 Calcium and trace mineral supplements |
05/30/1995 | US5420287 1,2 diarylcyclopentenyl compounds for the treatment of inflammation |
05/30/1995 | US5420243 Transforming growth factor |
05/30/1995 | US5420135 Substituted quinoline derivatives |
05/30/1995 | CA2048235C Lowering of blood uric acid levels |
05/26/1995 | WO1995014017A1 Non-peptide tachykinin receptor antagonists |
05/26/1995 | WO1995013803A1 Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis |
05/26/1995 | WO1995013767A1 Osteogenic product and process |
05/26/1995 | CA2176735A1 Non-peptide tachykinin receptor antagonists |
05/26/1995 | CA2176143A1 Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis |
05/24/1995 | CN1028528C Salts of optically active 4-hydroxy-8-(3-lower alkoxy-4-phenylsulfinylphenyl) pyrazolo |1,5-a¨-1,3,5-triazines |
05/18/1995 | WO1995013302A1 Cathepsin-l-specific inhibitor polypeptide |
05/18/1995 | CA2151059A1 Cathepsin-l-specific inhibitor polypeptide |
05/17/1995 | EP0652872A1 Optically pure salts of pyridinylmethyl sulfinyl-1h-benzimidazole compounds |
05/16/1995 | US5416117 Cyclopropenone derivatives |
05/11/1995 | WO1995012389A1 Multilamellar liposomal arachidonic acid metabolite formulations |
05/11/1995 | WO1995012388A1 Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations |
05/11/1995 | CA2175896A1 Methods of treatment using unilamellar liposomal arachidonic acid metabolite formulations |
05/11/1995 | CA2175057A1 Multilamellar liposomal arachidonic acid metabolite formulations |
05/10/1995 | EP0651765A1 Analogs of pth and pthrp, their synthesis and use for the treatment of osteoporosis |
05/10/1995 | EP0651738A1 Natural amino acid derivatives as metalloproteinase inhibitors |
05/09/1995 | US5413997 Triphenylmethane derivatives |
05/04/1995 | WO1995011883A1 1,2-diarylcyclopentenyl compounds for the treatment of inflammation |
05/04/1995 | WO1995011684A1 Antagonistic inhibitor against mesenchymal cell growth |
05/04/1995 | WO1995006077A3 Polymeric matrices and their uses in pharmaceutical compositions |
05/04/1995 | CA2170736A1 1,2-diarylcyclopentenyl compounds for the treatment of inflammation |
05/03/1995 | EP0650480A1 1-arylsulphonyl, arylcarbonyl and 1-arylphosphonyl-3-phenyl-1,4,5,6-tetrahydropyridazines |
05/03/1995 | EP0650361A1 Compositions for the treatment of arthritis containing phosphonates and nsaids |
05/03/1995 | EP0569541B1 Growth factor containing matrix for the treatment of cartilage lesions |
05/03/1995 | CN1102107A Gucixiao capable of removing spur and preparation technology thereof |
05/02/1995 | US5412145 P2'-modified hydroxamic acid collagenase inhibitors |
05/02/1995 | CA1335451C Substituted tetralins, chromans and related compounds in the treatment of asthma, arthritis and related diseases |
04/27/1995 | WO1995011303A1 Cntf family antagonists |
04/27/1995 | WO1995011221A1 Calcium receptor-active arylalkyl amines |
04/27/1995 | WO1995011029A1 Combination of bisphosphonates and growth hormone secretagogues |
04/27/1995 | WO1995011013A2 Combination of progesterone antagonists and anti-oestrogens with partial agonistic action for use in hormone-replacement therapy for peri- and post-menopausal women |
04/27/1995 | CA2173333A1 Combination of bisphosphonates and growth hormone secretagogues |
04/26/1995 | EP0649309A1 Use of particles of a biocompatible, bioabsorbable calcium salt as active principle in the preparation of a medicament for local treatment of bone demineralizing diseases |
04/26/1995 | CN1101915A New 19-nor steroids having a phenoxyalkylsulphonamide or phenoxyalkylsulphonylurea chain in position llbeta, preparation process and intermediates, use as medicaments and pharmaceutical compositions.. |
04/25/1995 | US5409911 Prostaglandin analog for treating osteoporosis |
04/20/1995 | WO1995010518A1 ALKOXY ALKYL CARBAMATES FROM IMIDAZO (1,2-a)PYRIDINES |
04/20/1995 | WO1995010271A2 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders |
04/19/1995 | EP0648120A1 Use of phosphonates for the treatment of osteoporosis |
04/19/1995 | CN1101549A Herbal medicine health cosmetic series products and its preparing method |
04/19/1995 | CN1028237C Composition for stimulating chondrocytes and osteoblasts, method for its production |
04/13/1995 | WO1995007934A3 Il8 inhibitors |
04/13/1995 | WO1995000501A3 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
04/12/1995 | EP0647266A1 D-enzyme compositions and methods of their use |
04/11/1995 | US5405757 Synthesis of human procollagens and collagens in recombinant DNA systems |
04/11/1995 | US5405620 Pharmaceutical composition for treating mucoviscidosis and chronic pain syndromes deriving from degenerative locomotor diseases or tumorous origin |
04/05/1995 | EP0646578A1 Phenyl carboxamide-isoxazole-derivatives and salts, process for their preparation, their use as pharmaceuticals, and pharmaceutical compositions containing them |
04/05/1995 | EP0646119A1 Quaternary nitrogen-containing phosphonate compounds for treating abnormal calcium and phosphate metabolism as well as dental calculus and plaque |
04/05/1995 | CN1100939A Lianhuangsong pill and capsule and its preparation method |